Back to Journals » Clinical Epidemiology » Volume 5 » Issue 1
Review
The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
18,942 | Dovepress* | 13,805+ | 2,227 | 16,032 | |
PubMed Central* | 5,137 | 1,081 | 6,218 | ||
Totals | 18,942 | 3,308 | 22,250 | ||
*Since 26 April 2013 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 1 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar